why choose us

First received: May 22, 2023

Clinical Trial: A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Multicenter, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Hepatic Function and Participants With Mild, Moderate, or Severe Hepatic Impairm

Brief Summary: The main purpose of this study is to measure how much of LY3502970 gets into the bloodstream and how long it takes the body to eliminate it in participants with mild, moderate and severe impaired liver function compared to participants with normal liver function.The safety and tolerability of LY3502970 will also be evaluated.The study may last up to 6 weeks for each participant including the screening period.

Read more